A new melanoma vaccine has shown its mettle in battling the deadly skin cancer in a new trial. People with advanced melanomas who received the vaccine plus Merck's cancer drug Keytruda were 49% ...

After surgery, the team analyzed and compared the tumor tissue with the healthy tissue of the same patient to find unique ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

Texas Oncology locations in Austin and Dallas are two of the 165 global sites testing a Moderna mRNA vaccine for the deadly melanoma skin cancer. Similar mRNA vaccines also are being tested on ...

While to date, no large, randomized trial has demonstrated an overall survival advantage to the use of a melanoma vaccine, investigations have continued, in part because vaccines have the ...

New data from a phase 2b trial of Moderna and MSD’s neoantigen melanoma vaccine may be strong enough to consider filing for accelerated approval before a phase 3 programme. The new results from ...

The different melanoma vaccines under investigation in multicenter phase III trials are reviewed and the concept of chemoprevention in melanoma is discussed. A retrospective review of the ...

A canine melanoma vaccine has received a full license from the US Department of Agriculture, the first therapeutic cancer vaccine approved for human or animal use. The San Diego–based Vical sees ...

An important trial of the world's first "personalised" mRNA vaccine against the deadliest form of skin cancer - melanoma - is now under way in the UK. Steve Young, 52, from Stevenage, Herts ...